Clinical Trial Update: Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sequential therapy with Everolimus followed by STZ-5FU in advanced pancreatic neuroendocrine tumors has completed and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Everolimus (everolimus)
• Streptozotocin (streptozotocin)

Snippet

Sponsor: Grupo Espanol de Tumores Neuroendocrinos | Conditions: Neuroendocrine Tumors | Phase 3 | Status: COMPLETED | Results posted: 2025-05-11